Nomura Boosts Celgene Target, Downgrades Receptos After Merger News

By: via Benzinga
In a report published Wednesday, Nomura analyst M. Ian Somaiya mentioned that the purchase of Receptos Inc (NASDAQ: RCPT) by Celgene ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.